A Republican congressional committee chairman is demanding that the Food and Drug Administration (FDA) turn over documents relating to the agency’s decision not to regulate CBD products. Rep. James Comer (R-KY), chair of the House Oversight and Accountability Committee, sent a letter to FDA Commissioner Robert Califf on Monday, announcing an investigation into the agency’s […]| Marijuana Moment
A key House committee is calling on Food and Drug Administration (FDA) to “continue and increase” enforcement against CBD companies that make unsanctioned claims about the benefits benefits of cannabidiol as the agency works with Congress to develop a regulatory pathway for the product. The panel separately noted the U.S. Department of Veterans Affairs’s (VA) […]| Marijuana Moment